Teleconference Call Scheduled For 10:00am EST Today
LENEXA, Kan., Feb. 5 /PRNewswire-FirstCall/ -- Mediware Information Systems, Inc. (Nasdaq: MEDW), a provider of ClosedLoop(TM) clinical systems for blood and medication management, reported total revenue for the second quarter of fiscal year 2008 of $8,659,000 compared to $11,262,000 in the comparable quarter in fiscal year 2007. Net loss for the quarter was $337,000, or a loss of four cents per fully diluted share, compared to net income of $905,000, or eleven cents per fully diluted share in the comparable quarter of fiscal year 2007.
For the six-month period ended December 31, 2007, Mediware reported total revenue of $19,403,000 compared to $19,737,000 in the comparable period in fiscal year 2007. Net income for the six months ended December 31, 2007 was $126,000, or one cent per fully diluted share, compared to net income of $1,069,000, or thirteen cents per fully diluted share in the comparable period of fiscal year 2007. The six month results for Fiscal 2008 were hampered by a $225,000 non cash write-off of certain deferred tax assets and a cash charge of $377,000 associated with the organizational restructuring announced in July 2008.
"As anticipated, we experienced reduced revenue due to the pipeline gap following the completion of the blood management sunset program," said Kelly Mann, Mediware's president and chief executive officer. "The quarter's performance was also impacted by delays in contracting for medication management products due to the complex sales environment. However, as we continue to refresh our sales pipeline, we are encouraged that our year to date revenue is comparable to last year's record levels."
Mann Continues: "Despite
|SOURCE Mediware Information Systems, Inc.|
Copyright©2008 PR Newswire.
All rights reserved